Journal of Oncology Practice Goes to Monthly Distribution with New and Enhanced Resources

James O. Armitage, MD, Named New Deputy Editor
For immediate release
January 14, 2016


Julianne Lee
(571) 483-1381

ALEXANDRIA, Va. -- The American Society of Clinical Oncology (ASCO) announced today that the Journal of Oncology Practice (JOP) will be printed on a monthly basis and offer new resources to supply oncology professionals with cutting-edge information on cancer care delivery. Doubling its content, the expanded journal also features clinical information from a multidisciplinary care team perspective led by new Deputy Editor, James O. Armitage, MD.

"The Journal of Oncology Practice seeks not only to provide valuable information to oncologists, but also to respond to the changing landscape of cancer care," said John V. Cox, DO, MBA, FACP, FASCO, and Editor-in-Chief of JOP. "Recognizing the shifting needs of the modern cancer community, JOP is expanding on its previous framework to make research findings more accessible and to provide oncologists with information covering all aspects of cancer care."

The print version of JOP will now be delivered on a monthly basis in its own solo mailing, doubling its frequency from six to twelve issues a year. All original reports will be presented in a novel, standardized format called ReCAP (Research Contributions Abbreviated for Print) - a short structured, summary of the study which highlights the central question being asked by the work, and outlines the main findings of the authors.  ReCAP will provide more information than a classic abstract. The relevance of the work for practicing oncologists will be emphasized, as well as any factors that might affect interpretation of the study results.  The full manuscript will be available online and is the official version of record.  ReCAPs are intended to meet the needs of busy clinicians who need a concise overview and to increase the audience for this content.

In addition, each issue of JOP will now expand to include three clinical reviews that will focus on pertinent problems in delivering care. Dr. Armitage has been selected as the Deputy Editor of the new Clinical Review section, which provides highly practical, clinical reviews authored by thought leaders in oncology and relevant subspecialties. Additional experts will provide commentaries to accompany each review.

Currently, Dr. Armitage is the Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center and past president of both ASCO and the American Society of Blood and Marrow Transplantation in addition to serving on numerous boards around the world. In his four decades of practice, Dr. Armitage has become globally recognized as a leading expert on non-Hodgkin lymphoma, and has played a critical role in advancing bone marrow transplantation. He begins his tenure as Deputy Editor of JOP having served on the Journal of Clinical Oncology Editorial Board and as Editor-in-Chief of The ASCO Post.

"Our goal is to expand on the journal to provide more insight into how we can deliver care efficiently and effectively," said Dr. Armitage. "These changes will make JOP a go-to resource for practicing oncologists, with information that can help them improve the quality of care they provide."

The expanded content and frequency will be delivered by a new publishing partner, Harborside Press. Harborside currently publishes The ASCO Post and is recognized in the industry as a provider of high-quality cancer information across a wide variety of media.

"The expansion of JOP represents an exciting new collaboration between ASCO and Harborside Press," said Jack Gentile, Chairman of Harborside Press. "Working together with ASCO staff, we will strive to provide critical publishing, editorial, and sales services for the journal." 

For more information on the enhanced JOP, visit 

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds groundbreaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit Patient-oriented cancer information is available at Cancer.Net.